Curetalks

Currently, very little is known about the impact of COVID-19 on reproduction and pregnancy. But as the COVID 19 pandemic began to affect lives around the world, out of an abundance of caution, the ASRM task force released a mandate on March 17th, 2020 recommending fertility clinics to suspend all new infertility treatments, cancel embryo transfers, and suspend all elective surgeries. Almost a month later, in an update#2 released on April 13, the ASRM recommends “While it is not yet prudent to resume non-emergency infertility procedures, the Task Force recognizes it is also time to begin to consider strategies and best practices for resuming time-sensitive fertility treatments in the face of COVID-19.”  We are talking to reproductive endocrinologist and virologist Dr Cindy Duke and infertility specialist Dr Aimee Eyvazzadeh to learn about the rapidly changing recommendations in this field, how the patients are getting affected and the future landscape of infertility treatments.